Zydus Gets USFDA Approval for Generic Prostate Cancer Drug
By Rediff Money Desk, New Delhi Sep 28, 2024 17:49
Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment drug. The drug will be produced at the company's Moraiya, Ahmedabad facility.
New Delhi, Sep 28 (PTI) Zydus Lifesciences on Saturday said it has received approval from the US health regulator to produce generic prostate cancer treatment drug.
The company has received approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide capsules (40 mg), it said in a regulatory filing.
Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
The drug will be produced at the group's manufacturing site in Moraiya, Ahmedabad, Zydus said.
As per IQVIA MAT July 2024 data, Enzalutamide capsules (40 mg) had annual sales of USD 869.4 million in the US.
The group now has 400 approvals and has filed over 465 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.
The company has received approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide capsules (40 mg), it said in a regulatory filing.
Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
The drug will be produced at the group's manufacturing site in Moraiya, Ahmedabad, Zydus said.
As per IQVIA MAT July 2024 data, Enzalutamide capsules (40 mg) had annual sales of USD 869.4 million in the US.
The group now has 400 approvals and has filed over 465 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 10.67 (+ 2.50)
- 69776634
- Spicejet Ltd.
- 58.71 ( -5.06)
- 51299261
- Standard Capital
- 1.52 (+ 9.35)
- 46654145
- GACM Technologies
- 0.95 ( -5.00)
- 28597471
- GTL Infrastructure
- 2.53 (+ 4.98)
- 19162474
MORE NEWS
Amul Turnover Rises 8% to Rs 59,445 Cr in FY24
GCMMF, the operator of Amul brand, reports an 8% increase in turnover to Rs 59,445...
REC Raises USD 500 Million via Green Bond
REC Ltd has raised USD 500 million through green dollar bonds to finance renewable...
Agri Startups Training: Chouhan Calls for...
Agriculture Minister Shivraj Singh Chouhan emphasizes the importance of training for...